COVID vaccine

From the onset of the COVID-19 pandemic, researchers have been engaged in forecasting the potential economic and human costs associated with an uncontrolled large-scale pandemic, as well as the corresponding benefits that could be derived from an

We spoke at length about the public's eroded trust in public health “institutions” due to their actions and inactions -- perceived and real -- during the pandemic.

The Wall Street Journal published a news article on January 5, “Why It Feels Like Everyone You Know Is Getting COVID-19,” which contained several worrisome observations.

Our conversation begins with the emergence of sub-variant of Omicron EG.5 and its impact, particularly in large cities like Manhattan.

Here we go again — another armchair expert holding forth on scientific and medical issues she misunderstands.

Over the past several years, the medical community has learned, to its dismay, that we can experience a “twin-demic” of winter infectious diseases – simultaneous COVID-19 and flu outbreaks resulting in intense stresses on healthcare delivery.

We have learned a lot about the SARS-CoV-2 virus during the three years of the COVID-19 pandemic. For example, new viral variants, such as the many subtypes of Omicron, are less susceptible to the vaccines developed to protect against th

It is not uncommon for legislators to introduce bills that they know won’t pass but that have symbolic value of some sort, like renaming a bridge or freeway to honor a constituent.  Every so often, however, they propose something that they in

Authors: Kevin M. Ban and Robert Popovian (an ACSH advisor)

Join ACSH directors of bio-sciences and medicine Cameron English and Dr. Chuck Dinerstein as they break down these stories on episode 12 of the Science Dispatch podcast: